InsidersTradesSigma
Follow the Medicamen Organics stock price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €3.3bn. The latest transaction was filed on 19 June 2026 (Acquisition). Among the most active insiders: Pradeep Kumar Jain. The full history is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 19,211 of 29,063 companies
41.3
score / 100
Value31
Quality52
FCF yld-11%
Earn yld2.8%
EV/EBITDA17.5x
ROE4.0%
Gross mgn49%
Net mgn4.9%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 June 2026
Declarations2 total
2,000,000 sharesEquity sharesPreferential AllotmentSEBI:8bc45bc3cad2c47f27d5d6a320e70c9457c4b29a
Canonical exit: 17 Sept 2026 (T+90)
714,285 sharesEquity sharesPreferential AllotmentSEBI:0c3b8e32e4ae77a97e6b86e8eb4959943dafb752
Canonical exit: 17 Sept 2026 (T+90)
2 of 2 declarations
Acerca de Medicamen Organics
Medicamen Organics es una empresa que cotiza en la Bolsa de Bombay, especializada en la fabricación de productos farmacéuticos. Se centra en el desarrollo de medicamentos genéricos y formulaciones innovadoras.